TNF and diabetes mellitus: Emodin-loaded Poly-PEGMA-DMAEMA-MAM nanoparticles have shown efficacy in alleviating diabetic neuropathic pain by inhibiting purinergic P2X3 receptor expression, reducing TNF-α levels, and suppressing ERK1/2 activation in the dorsal root ganglia of type 2 diabetic rats [178].